Proteome Sciences (PRM)

 

PRM Share PerformanceMore

52 week high5.6400 22/05/17
52 week low2.6100 18/10/17
52 week change -2.1500 (-40.95%)
4 week volume6,515,659 21/12/17

Media for (PRM)

Presenter: Christopher Pearce
29/05/2014

Latest NewsMore

Holding(s) in Company

RNS Number: 1697W Proteome Sciences PLC 10 November 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Proteome S...

Director Deals - Proteome Sciences PLC (PRM)

Martin Diggle, Non Executive Director, bought 20,000 shares in the company on the 6th November 2017 at a price of 3.17p....

Director/PDMR Shareholding

RNS Number: 9351V Proteome Sciences PLC 08 November 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Director/PDMR Shareholding T he Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 6 November 2017, it purchased 20,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares")...

Director Deals - Proteome Sciences PLC (PRM)

Martin Diggle, Non Executive Director, bought 184,460 shares in the company on the 25th October 2017 at a price of 3.18p. T...

Holding(s) in Company

RNS Number: 8458U Proteome Sciences PLC 27 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: PROTEOME...

Director/PDMR Shareholding

RNS Number: 8464U Proteome Sciences PLC 27 October 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Director/PDMR Shareholding T he Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 24 October 2017 and 25 October 2017, it purchased 75,000 and 109,460 ordinary shares of 1p each, respectively, in the cap...

Director/PDMR Shareholding

RNS Number: 3433U Proteome Sciences PLC 23 October 2017 Proteome Sciences plc ("Proteome Sciences" or the "Company") Director/PDMR Shareholding T he Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 18 and 19 October 2017 it purchased 256,520 and 193,100 ordinary shares of 1p each, respectively, in the capital of the Com...

Holding(s) in Company

RNS Number: 3432U Proteome Sciences PLC 23 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: PROTEOME ...

Fundamental DataMore

EPS-0.96
Dividend yield0 %

Latest discussion posts More

  • A view of Biotech from HuffPost

    See https://www.huffingtonpost.com/entry/biotech-stocks-turning-attention-away-from-bitcoin_us_5a1efb17e4b039242f8c811a TP
    4-Jan-2018
    The Potter
  • Re: Strange sideways move......

    Interims on March 28th last year (SP High 4.19p - low 4p - and its marginally lower now!) were reasonable, but, as I said, the SP has merely reflected a lot of the ...
    21-Dec-2017
    Andy Reilly
  • Re: Strange sideways move......

    Hope your right about news AR, if not, when something flatlines it's normally pronounced dead!.........?
    14-Dec-2017
    CDLANEY

Users' HoldingsMore

Users who hold Proteome Sciences also hold..

Codes & Symbols

ISINGB0003104196
SymbolsPRM, LSE:PRM, PRM.L, PRM:LN, LON:PRM, XLON:PRM

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account